Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL11764114 | 1.00 | TSHR (0.84) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL475463 | 0.92 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Propanol SCHEMBL11193775 | 0.92 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL11578306 | 0.92 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL1878023 | 0.92 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL20958140 | 0.92 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Methyl Alcohol SCHEMBL3121264 | 0.92 | TSHR (0.89) | TSHRALDH1A1LMNAABCC4MAPT | |
| SCHEMBL28174670 | 0.92 | TSHR (0.89) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Hydrogen Peroxide SCHEMBL11725698 | 0.92 | TSHR (0.89) | TSHRALDH1A1LMNAHSD17B10KMT2A | |
| SCHEMBL23539923 | 0.92 | TSHR (1.00) | TSHRALDH1A1ABCC4MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216713-A1 | ENERGY AUGMENTATION STRUCTURES FOR USE WITH ENERGY EMITTERS AND COLLECTORS | IMMUNOLIGHT, LLC (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240148571-A1 | COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND/OR DOWN CONVERTERS | IMMUNOLIGHT, LLC | 2024-05-09 | — | — | US | disclosed |
| US-11964167-B2 | Energy augmentation structures for use with energy emitters and collectors | IMMUNOLIGHT, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| US-11938011-B2 | Color enhancement utilizing up converters and/or down converters | IMMUNOLIGHT, LLC | 2024-03-26 | — | — | US | disclosed |
| CN-113242750-B | Microcapsule | 西姆莱斯股份公司 | 2023-08-22 | — | — | CN | disclosed |
| EP-3935132-A1 | ENERGY AUGMENT STRUCTURES FOR USE WITH ENERGY EMITTERS AND COLLECTORS | Immunolight, Llc. (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20200323711-A1 | COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND/OR DOWN CONVERTERS | IMMUNOLIGHT, LLC (US) | 2020-10-15 | — | — | US | disclosed |
| EP-2601042-A2 | COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND DOWN CONVERTERS | Immunolight, Llc. (US) | 2013-06-12 | — | — | EP | disclosed |
| US-20120064134-A1 | COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND DOWN CONVERTERS | IMMUNOLIGHT, LLC (US) | 2012-03-15 | — | — | US | disclosed |
| WO-2012019081-A2 | COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND DOWN CONVERTERS | IMMUNOLIGHT, LLC (US) | 2012-02-09 | — | — | WO | disclosed |
| US-20040257330-A1 | Electrophoretic particles and process for producing the same, and electrophoretic display using same | CANON KABUSHIKI KAISHA (JP) | 2004-12-23 | — | — | US | disclosed |
| WO-2004067593-A2 | ELECTROPHORETIC PARTICLES | CANON KABUSHIKI KAISHA (JP) | 2004-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216713-A1 | ENERGY AUGMENTATION STRUCTURES FOR USE WITH ENERGY EMITTERS AND COLLECTORS | ETFA, SLC25A1, TIMM44 | TSHR 3052/4885ALDH1A1 865/4885LMNA 2947/4885 |
| US-11964167-B2 | Energy augmentation structures for use with energy emitters and collectors | ETFA, SLC25A1, TIMM44 | TSHR 3052/4885ALDH1A1 865/4885LMNA 2947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.